Effects of POH in Combination with STI571 on the Proliferation and Apoptosis of K562 Cells

The effects of monoterpene perilly alcohol (POH) alone or in combination with STI571 on the proliferation and apoptosis of the cell line K562 positive for Bcr/Abl were investigated. By using cell culture, the effect of the drugs on the proliferation of the cells was studied. TUNEL and flow cytometry...

Full description

Saved in:
Bibliographic Details
Published inCurrent medical science Vol. 24; no. 1; pp. 41 - 44
Main Author 陈燕 胡东
Format Journal Article
LanguageEnglish
Published China Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022 2004
Subjects
Online AccessGet full text
ISSN1672-0733
2096-5230
1993-1352
2523-899X
DOI10.1007/BF02830702

Cover

Abstract The effects of monoterpene perilly alcohol (POH) alone or in combination with STI571 on the proliferation and apoptosis of the cell line K562 positive for Bcr/Abl were investigated. By using cell culture, the effect of the drugs on the proliferation of the cells was studied. TUNEL and flow cytometry assay of FITC-Annexin V and PI labeled cells were applied to detect the effects of the drugs on the apoptosis of the cells. The results showed that at 36 h, IC50 of POH on K562 positive for Bcr/Abl and HL-60 negative for Bcr/Abl were 81.0±11.3 μmol/L and 113.6±23.4μmol/L respectively (P>0.05). POH could inhibit the proliferation of K562 in a time and dosedependent manner with the inhibitory rate of 100 μmol/L POH on K562 cells at 36 h being (53.2±3.65)%. K562 cells were more sensitive to STI571 than POH. IC50 of STI571 on K562 cells in 36 h was (0. 256±0. 054) μmol/L. In a time and dose-dependent manner, POH induced the apoptosis of K562 cells with the percentage of apoptotic cells by 100 μmol/L POH at 40 h being (21.0±3.3)%. Both 100 μmo/L POH and 0.2 μmol/L STI571 had the same inhibitory effects on the K562 cells at 36 h. But at 12 and 24 h, the inhibitory rate of POH was significantly higher than that ofSTI571 (P~0.05) and the ability of STI571 inducing apoptosis at 36 h was greater than that of POH. 50 μmol/L, 100 μmol/L and 200 μmol/L POH in combination with 0.2 μmol/L STI571 could obviously increase the inhibitory effects on the cellular proliferation. Combined use of 50 μmol/L, 100 μmol/L, 200 μmol/L with 0.2 μmol/L STI571 could strongly induced apoptosis, es-pecially 200 μmol/L POH in combination with 0.2 μmol/L STI571. It was concluded that the antileukemia effect of POH had no obvious Bcr/Abl positive selectivity. POH can inhibit the proliferation of K562 and induce the apoptosis in a time- and dose-dependent manner. K562 cells were more sensitive to STI571 than POH. POH in combination with STI571 could obviously enhance the abilities of STI571 inhibiting the proliferation and inducing apoptosis of K562 cells.
AbstractList R3; Summary: The effects of monoterpene perilly alcohol (POH) alone or in combination with STI571on the proliferation and apoptosis of the cell line K562 positive for Bcr/Abl were investigated. By using cell culture, the effect of the drugs on the proliferation of the cells was studied. TUNEL and flow cytometry assay of FITC-Annexin V and PI labeled cells were applied to detect the effects of the drugs on the apoptosis of the cells. The results showed that at 36 h, IC50 of POH on K562positive for Bcr/Abl and HL-60 negative for Bcr/Abl were 81.0±11.3 μmol/L and 113.6±23.4μmol/L respectively (P>0.05). POH could inhibit the proliferation of K562 in a time- and dosedependent manner with the inhibitory rate of 100μmol/L POH on K562 cells at 36 h being (53.2±3.65) %. K562 cells were more sensitive to STI571 than POH. IC50 of STI571 on K562 cells in 36h was (0. 256±0. 054) μmol/L. In a time- and dose-dependent manner, POH induced the apoptosis of K562 cells with the percentage of apoptotic cells by 100μmol/L POH at 40 h being (21.0±3.3)%. Both 100 μmo/L POH and 0. 2 μmol/L STI571 had the same inhibitory effects on the K562cells at 36 h. But at 12 and 24 h, the inhibitory rate of POH was significantly higher than that of ST1571 (P<0.05) and the ability of STI571 inducing apoptosis at 36 h was greater than that of POH. 50 μmol/L, 100 μmol/L and 200 μmol/L POH in combination with 0. 2 μmol/L STI571could obviously increase the inhibitory effects on the cellular proliferation. Combined use of 50μmol/L, 100 μmol/L, 200μmol/L with 0.2μmol/L STI571 could strongly induced apoptosis, especially 200 μmol/L POH in combination with 0.2 μmol/L STI571. It was concluded that the antileukemia effect of POH had no obvious Bcr/Abl positive selectivity. POH can inhibit the proliferation of K562 and induce the apoptosis in a time- and dose-dependent manner. K562 cells were more sensitive to STI571 than POH. POH in combination with STI571 could obviously enhance the abilities of ST1571 inhibiting the proliferation and inducing apoptosis of K562 cells.
The effects of monoterpene perilly alcohol (POH) alone or in combination with STI571 on the proliferation and apoptosis of the cell line K562 positive for Bcr/Abl were investigated. By using cell culture, the effect of the drugs on the proliferation of the cells was studied. TUNEL and flow cytometry assay of FITC-Annexin V and PI labeled cells were applied to detect the effects of the drugs on the apoptosis of the cells. The results showed that at 36 h, IC50 of POH on K562 positive for Bcr/Abl and HL-60 negative for Bcr/Abl were 81.0±11.3 μmol/L and 113.6±23.4μmol/L respectively (P>0.05). POH could inhibit the proliferation of K562 in a time and dosedependent manner with the inhibitory rate of 100 μmol/L POH on K562 cells at 36 h being (53.2±3.65)%. K562 cells were more sensitive to STI571 than POH. IC50 of STI571 on K562 cells in 36 h was (0. 256±0. 054) μmol/L. In a time and dose-dependent manner, POH induced the apoptosis of K562 cells with the percentage of apoptotic cells by 100 μmol/L POH at 40 h being (21.0±3.3)%. Both 100 μmo/L POH and 0.2 μmol/L STI571 had the same inhibitory effects on the K562 cells at 36 h. But at 12 and 24 h, the inhibitory rate of POH was significantly higher than that ofSTI571 (P~0.05) and the ability of STI571 inducing apoptosis at 36 h was greater than that of POH. 50 μmol/L, 100 μmol/L and 200 μmol/L POH in combination with 0.2 μmol/L STI571 could obviously increase the inhibitory effects on the cellular proliferation. Combined use of 50 μmol/L, 100 μmol/L, 200 μmol/L with 0.2 μmol/L STI571 could strongly induced apoptosis, es-pecially 200 μmol/L POH in combination with 0.2 μmol/L STI571. It was concluded that the antileukemia effect of POH had no obvious Bcr/Abl positive selectivity. POH can inhibit the proliferation of K562 and induce the apoptosis in a time- and dose-dependent manner. K562 cells were more sensitive to STI571 than POH. POH in combination with STI571 could obviously enhance the abilities of STI571 inhibiting the proliferation and inducing apoptosis of K562 cells.
The effects of monoterpene perilly alcohol (POH) alone or in combination with STI571 on the proliferation and apoptosis of the cell line K562 positive for Bcr/Abl were investigated. By using cell culture, the effect of the drugs on the proliferation of the cells was studied. TUNEL and flow cytometry assay of FITC-Annexin V and PI labeled cells were applied to detect the effects of the drugs on the apoptosis of the cells. The results showed that at 36 h, IC50 of POH on K562 positive for Bcr/Abl and HL-60 negative for Bcr/Abl were 81.0 +/- 11.3 micromol/L and 113.6 +/- 23.4 micromol/L respectively (P>0.05). POH could inhibit the proliferation of K562 in a time- and dose-dependent manner with the inhibitory rate of 100 micromol/L POH on K562 cells at 36 h being (53.2 +/- 3.65)%. K562 cells were more sensitive to STI571 than POH. IC50 of STI571 on K562 cells in 36 h was (0.256 +/- 0.054) micromol/L. In a time- and dose-dependent manner, POH induced the apoptosis of K562 cells with the percentage of apoptotic cells by 100 micromol/L POH at 40 h being (21.0 +/- 3.3)%. Both 100 micromo/L POH and 0.2 micromol/L STI571 had the same inhibitory effects on the K562 cells at 36 h. But at 12 and 24 h, the inhibitory rate of POH was significantly higher than that of STI571 (P<0.05) and the ability of STI571 inducing apoptosis at 36 h was greater than that of POH. 50 micromol/L, 100 micromol/L and 200 micromol/L POH in combination with 0.2 micromol/L STI571 could obviously increase the inhibitory effects on the cellular proliferation. Combined use of 50 micromol/L, 100 micromol/L, 200 micromol/L with 0.2 micromol/L STI571 could strongly induced apoptosis, especially 200 micromol/L POH in combination with 0.2 micromol/L STI571. It was concluded that the antileukemia effect of POH had no obvious Bcr/Abl positive selectivity. POH can inhibit the proliferation of K562 and induce the apoptosis in a time- and dose-dependent manner. K562 cells were more sensitive to STI571 than POH. POH in combination with STI571 could obviously enhance the abilities of STI571 inhibiting the proliferation and inducing apoptosis of K562 cells.
The effects of monoterpene perilly alcohol (POH) alone or in combination with STI571 on the proliferation and apoptosis of the cell line K562 positive for Bcr/Abl were investigated. By using cell culture, the effect of the drugs on the proliferation of the cells was studied. TUNEL and flow cytometry assay of FITC-Annexin V and PI labeled cells were applied to detect the effects of the drugs on the apoptosis of the cells. The results showed that at 36 h, IC50 of POH on K562 positive for Bcr/Abl and HL-60 negative for Bcr/Abl were 81.0 +/- 11.3 micromol/L and 113.6 +/- 23.4 micromol/L respectively (P>0.05). POH could inhibit the proliferation of K562 in a time- and dose-dependent manner with the inhibitory rate of 100 micromol/L POH on K562 cells at 36 h being (53.2 +/- 3.65)%. K562 cells were more sensitive to STI571 than POH. IC50 of STI571 on K562 cells in 36 h was (0.256 +/- 0.054) micromol/L. In a time- and dose-dependent manner, POH induced the apoptosis of K562 cells with the percentage of apoptotic cells by 100 micromol/L POH at 40 h being (21.0 +/- 3.3)%. Both 100 micromo/L POH and 0.2 micromol/L STI571 had the same inhibitory effects on the K562 cells at 36 h. But at 12 and 24 h, the inhibitory rate of POH was significantly higher than that of STI571 (P<0.05) and the ability of STI571 inducing apoptosis at 36 h was greater than that of POH. 50 micromol/L, 100 micromol/L and 200 micromol/L POH in combination with 0.2 micromol/L STI571 could obviously increase the inhibitory effects on the cellular proliferation. Combined use of 50 micromol/L, 100 micromol/L, 200 micromol/L with 0.2 micromol/L STI571 could strongly induced apoptosis, especially 200 micromol/L POH in combination with 0.2 micromol/L STI571. It was concluded that the antileukemia effect of POH had no obvious Bcr/Abl positive selectivity. POH can inhibit the proliferation of K562 and induce the apoptosis in a time- and dose-dependent manner. K562 cells were more sensitive to STI571 than POH. POH in combination with STI571 could obviously enhance the abilities of STI571 inhibiting the proliferation and inducing apoptosis of K562 cells.The effects of monoterpene perilly alcohol (POH) alone or in combination with STI571 on the proliferation and apoptosis of the cell line K562 positive for Bcr/Abl were investigated. By using cell culture, the effect of the drugs on the proliferation of the cells was studied. TUNEL and flow cytometry assay of FITC-Annexin V and PI labeled cells were applied to detect the effects of the drugs on the apoptosis of the cells. The results showed that at 36 h, IC50 of POH on K562 positive for Bcr/Abl and HL-60 negative for Bcr/Abl were 81.0 +/- 11.3 micromol/L and 113.6 +/- 23.4 micromol/L respectively (P>0.05). POH could inhibit the proliferation of K562 in a time- and dose-dependent manner with the inhibitory rate of 100 micromol/L POH on K562 cells at 36 h being (53.2 +/- 3.65)%. K562 cells were more sensitive to STI571 than POH. IC50 of STI571 on K562 cells in 36 h was (0.256 +/- 0.054) micromol/L. In a time- and dose-dependent manner, POH induced the apoptosis of K562 cells with the percentage of apoptotic cells by 100 micromol/L POH at 40 h being (21.0 +/- 3.3)%. Both 100 micromo/L POH and 0.2 micromol/L STI571 had the same inhibitory effects on the K562 cells at 36 h. But at 12 and 24 h, the inhibitory rate of POH was significantly higher than that of STI571 (P<0.05) and the ability of STI571 inducing apoptosis at 36 h was greater than that of POH. 50 micromol/L, 100 micromol/L and 200 micromol/L POH in combination with 0.2 micromol/L STI571 could obviously increase the inhibitory effects on the cellular proliferation. Combined use of 50 micromol/L, 100 micromol/L, 200 micromol/L with 0.2 micromol/L STI571 could strongly induced apoptosis, especially 200 micromol/L POH in combination with 0.2 micromol/L STI571. It was concluded that the antileukemia effect of POH had no obvious Bcr/Abl positive selectivity. POH can inhibit the proliferation of K562 and induce the apoptosis in a time- and dose-dependent manner. K562 cells were more sensitive to STI571 than POH. POH in combination with STI571 could obviously enhance the abilities of STI571 inhibiting the proliferation and inducing apoptosis of K562 cells.
Author 陈燕 胡东
AuthorAffiliation InstituteofHematology,UnionHospital,TongjiMedicalCollege,HuazhongUniversityofScienceandTechnology,Wuhan430022
AuthorAffiliation_xml – name: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022
Author_xml – sequence: 1
  fullname: 陈燕 胡东
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15165112$$D View this record in MEDLINE/PubMed
BookMark eNptkc9vVCEQx4mpsT_04h9g8OJB85SBBd471k1rG5u0ifXihQAPumzfwhbYtP3vxe6qifE0M8lnvvOdmUO0F1N0CL0G8hEIkZ8-nxLaMyIJfYYOYBhYB4zTvZYLSTsiGdtHh6UsCeFS0NkLtA8cBAegB-jHiffO1oKTx1eXZzhEPE8rE6KuIUV8H-oCf7s-5xJwK-vC4aucpuBd3gI6jvh4ndY1lfAk8pULiudumspL9NzrqbhXu3iEvp-eXM_PuovLL-fz44vOwkCha4Y9B8usoNw2U6aXQIQ2ZhyNmxnrGUhte-24aOa5GxkdDKc9l7OejZawI_Rhq3uvo9fxRi3TJsc2UdXl4-348GCUo4TMCBCARr_b0uuc7jauVLUKxTa_Orq0KUrCwIde8Aa-2YEbs3KjWuew0vlR_b5dA8gWsDmVkp1XNtSnq9Ssw6SAqF_vUX_f01re_9PyR_V_8NsdvEjx5i60zYy2tz5MTg1MCME5-wnyCpZn
CitedBy_id crossref_primary_10_1155_2014_953451
Cites_doi 10.1038/sj.leu.2401536
10.1182/blood.V96.10.3343
10.1182/blood.V97.7.2008
10.1093/jn/127.5.668
10.1093/jn/129.3.775S
10.1038/sj.leu.2402369
10.1182/blood.V96.9.3195
ClassificationCodes R3
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.1007/BF02830702
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1993-1352
2523-899X
EndPage 44
ExternalDocumentID tjykdxxb_e200401011
15165112
10_1007_BF02830702
9366655
Genre Journal Article
GroupedDBID -5E
-5G
-BR
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
29K
29~
2B.
2C~
2J2
2JN
2KG
2KM
2LR
2RA
2~H
30V
4.4
408
40D
40E
53G
5GY
5VS
6NX
8TC
8UJ
92F
92I
92L
95-
95.
95~
96X
AAAVM
AABHQ
AAJKR
AANXM
AARHV
AARTL
AAYIU
AAYQN
AAYTO
ABFTV
ABJOX
ABKCH
ABMNI
ABNWP
ABQBU
ABTMW
ACGFS
ACHXU
ACKNC
ACOMO
ACSNA
ACUDM
ADHIR
ADINQ
ADKPE
ADURQ
ADYFF
ADZKW
AEBTG
AEGNC
AEJHL
AEKMD
AEOHA
AEPYU
AETLH
AEXYK
AFWTZ
AFZKB
AGAYW
AGDGC
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHYZX
AIIXL
AJBLW
AJRNO
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
ARMRJ
AZFZN
B-.
BA0
BGNMA
CAG
CCEZO
CHBEP
CIEJG
COF
CQIGP
CS3
CSCUP
CW9
D-I
EBS
EJD
ESBYG
FA0
FEDTE
FNLPD
FRRFC
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GQ6
GQ7
H13
HF~
HG6
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IPNFZ
IXD
I~X
I~Z
J-C
JBSCW
JUIAU
KOV
M4Y
MA-
N2Q
NDZJH
NQJWS
NU0
O9-
O93
O9I
O9J
P9S
PF0
QOR
QOS
R-E
R89
R9I
RIG
ROL
RPX
RSV
S..
S16
S1Z
S27
S37
S3B
SAP
SCL
SDH
SHX
SMD
SNE
SNX
SOJ
SPISZ
SZ9
SZN
T13
TCJ
TGQ
TSG
TT1
TUC
U2A
U9L
UG4
VC2
W48
W91
WK8
Z7U
Z82
Z8V
ZOVNA
~A9
~WA
-05
-0E
-SE
-S~
2JY
406
5VR
92M
9D9
9DE
AACDK
AAHNG
AAIAL
AAJBT
AANZL
AAPKM
AASML
AATNV
AAUYE
AAYXX
AAYZH
ABAKF
ABBRH
ABDBE
ABDZT
ABECU
ABFSG
ABHQN
ABJNI
ABKZE
ABMQK
ABSXP
ABTEG
ABTKH
ABWNU
ABXPI
ACAOD
ACDTI
ACHSB
ACMDZ
ACMLO
ACOKC
ACSTC
ACZOJ
ADKNI
ADRFC
ADTPH
AEFQL
AEJRE
AEMSY
AESKC
AEVLU
AEZWR
AFBBN
AFDZB
AFHIU
AFLOW
AFOHR
AFQWF
AFUIB
AGJBK
AGMZJ
AGQEE
AGRTI
AHPBZ
AHSBF
AHWEU
AIAKS
AIGIU
AILAN
AITGF
AIXLP
AMXSW
AMYLF
AMYQR
AOCGG
ATHPR
AXYYD
AYFIA
BDATZ
CAJEE
CITATION
DDRTE
DNIVK
DPUIP
EBLON
EIOEI
FERAY
FFXSO
FIGPU
FINBP
FSGXE
GNWQR
GRRUI
IKXTQ
IWAJR
JZLTJ
LLZTM
NPVJJ
PT4
Q--
RHV
RT5
SCLPG
SDE
SISQX
SJYHP
SNPRN
SOHCF
SRMVM
SSLCW
STPWE
T8U
U1F
U1G
U5E
U5O
UOJIU
UTJUX
UZXMN
VFIZW
YLTOR
ZMTXR
ABQSL
ADHKG
CGR
CUY
CVF
ECM
EIF
NPM
7X8
AGQPQ
4A8
93N
PSX
ID FETCH-LOGICAL-c1921-199f51c3c625c511b87106abbddbe4bcf317ac8ae566245ed329b52857483dc03
ISSN 1672-0733
2096-5230
IngestDate Thu May 29 04:06:47 EDT 2025
Thu Jul 10 19:55:05 EDT 2025
Thu Apr 03 07:08:33 EDT 2025
Thu Apr 24 22:58:32 EDT 2025
Tue Jul 01 04:14:33 EDT 2025
Thu Nov 24 20:34:23 EST 2022
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords apoptosis
STI571
K562
proliferation
perillyl alcohol
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1921-199f51c3c625c511b87106abbddbe4bcf317ac8ae566245ed329b52857483dc03
Notes R965
R730.53
42-1679/R
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 15165112
PQID 71959865
PQPubID 23479
PageCount 4
ParticipantIDs wanfang_journals_tjykdxxb_e200401011
proquest_miscellaneous_71959865
pubmed_primary_15165112
crossref_citationtrail_10_1007_BF02830702
crossref_primary_10_1007_BF02830702
chongqing_backfile_9366655
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2004-00-00
PublicationDateYYYYMMDD 2004-01-01
PublicationDate_xml – year: 2004
  text: 2004-00-00
PublicationDecade 2000
PublicationPlace China
PublicationPlace_xml – name: China
PublicationTitle Current medical science
PublicationTitleAlternate Journal of Zuazhong University of Science and Technology: Medical Edition
PublicationTitle_FL JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY(MEDICAL SCIENCES)
PublicationYear 2004
Publisher Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022
Publisher_xml – name: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022
References L He (BF02830702_CR6) 1997; 127
M W Deininger (BF02830702_CR1) 2000; 96
E A Ariazi (BF02830702_CR7) 1999; 59
P L. Crowell (BF02830702_CR2) 1999; 129
M B Sahin (BF02830702_CR5) 1999; 13
S S Clark (BF02830702_CR8) 2002; 16
X Sun (BF02830702_CR10) 2001; 97
D Hu (BF02830702_CR4) 2001; 14
J T Belanger (BF02830702_CR3) 1998; 3
J T Thiesing (BF02830702_CR9) 2000; 96
References_xml – volume: 13
  start-page: 1581
  issue: 10
  year: 1999
  ident: BF02830702_CR5
  publication-title: Lukemia
  doi: 10.1038/sj.leu.2401536
– volume: 14
  start-page: 141
  issue: 3
  year: 2001
  ident: BF02830702_CR4
  publication-title: Clin Hematol J (Chinese)
– volume: 96
  start-page: 3343
  year: 2000
  ident: BF02830702_CR1
  publication-title: Blood
  doi: 10.1182/blood.V96.10.3343
– volume: 3
  start-page: 448
  issue: 6
  year: 1998
  ident: BF02830702_CR3
  publication-title: Altern Med Rev
– volume: 97
  start-page: 2008
  year: 2001
  ident: BF02830702_CR10
  publication-title: Blood
  doi: 10.1182/blood.V97.7.2008
– volume: 127
  start-page: 668
  issue: 5
  year: 1997
  ident: BF02830702_CR6
  publication-title: J Nutr
  doi: 10.1093/jn/127.5.668
– volume: 59
  start-page: 1917
  issue: 8
  year: 1999
  ident: BF02830702_CR7
  publication-title: Cancer Res
– volume: 129
  start-page: 775S
  issue: 3
  year: 1999
  ident: BF02830702_CR2
  publication-title: J. Nutr
  doi: 10.1093/jn/129.3.775S
– volume: 16
  start-page: 213
  issue: 2
  year: 2002
  ident: BF02830702_CR8
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2402369
– volume: 96
  start-page: 3195
  issue: 9
  year: 2000
  ident: BF02830702_CR9
  publication-title: Blood
  doi: 10.1182/blood.V96.9.3195
SSID ssj0057624
ssib031263182
ssj0002039635
ssib051367596
ssib034325102
Score 1.5726199
Snippet The effects of monoterpene perilly alcohol (POH) alone or in combination with STI571 on the proliferation and apoptosis of the cell line K562 positive for...
R3; Summary: The effects of monoterpene perilly alcohol (POH) alone or in combination with STI571on the proliferation and apoptosis of the cell line K562...
SourceID wanfang
proquest
pubmed
crossref
chongqing
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 41
SubjectTerms Antineoplastic Agents - pharmacology
Apoptosis - drug effects
Benzamides
Dose-Response Relationship, Drug
Drug Synergism
Fusion Proteins, bcr-abl - analysis
HL-60 Cells
Humans
Imatinib Mesylate
K562 Cells
K562细胞
Monoterpenes - pharmacology
Piperazines - pharmacology
Pyrimidines - pharmacology
STI571
单萜紫苏醇
细胞凋亡
细胞增殖
肿瘤抑制
Title Effects of POH in Combination with STI571 on the Proliferation and Apoptosis of K562 Cells
URI http://lib.cqvip.com/qk/85740A/20041/9366655.html
https://www.ncbi.nlm.nih.gov/pubmed/15165112
https://www.proquest.com/docview/71959865
https://d.wanfangdata.com.cn/periodical/tjykdxxb-e200401011
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwHLXKduGCQHx1wLDELmjK1CR2kh67aVMYYiDRSoNLZDsOHxtJoYk09tfz-8V2kqqbBFyqNomc1u_VfnaenwnZy1mIMZUSyVt4GKjkJRHLPYV-Sujxc93uDfjuLEoX7PScn49GpwPXUlPLA3V947qS_0EVjgGuuEr2H5DtCoUD8B7whVdAGF7_CuPj3ozx4X26byzlMNQ1oLZTrB_nb3js20cC6Ma6RC-LuaDNaV1Wy7qyqSRvQabs41T-6hbNmjbi-ivuTrTu53ANBBbYz9UfdE-BbDfbyfcjuyTkU0_NtDFy3nakbh6CDRrNKEYHqwm0cK1qwDbYY5pIk3O10XJPnB8dE8nidhV2PYBw-aPFEPRJhBKx7706T6E7dYdsB3Hso71zEcxcrwzDKrPBsfuu61G19qbtJk2mGMzawAr9CQpiXbNsDETa9V5lIcovA2kyv0_uWXzozBDkARnp8iH5bMlBq4ICOei3kg7IQZEc1JCDwkcgB10jBwUsaUcOLATJQVtyPCKLk-P5UerZjTQ8hXF3aCYquK9CBYNdBT9Owih5Egkp81xqJlUBIlKoRGjQ9gHjOg-DqeRBwmOWhLmahI_JVlmV-imhfKKkYKHg0TRiwk8EV7oImGRTFgR5wcdkp6s2EGLqAuPFsmkIo2QOJ1-7esyUjaDHnVAuMxee3UMxJq-6a5cmeOXGq146ODJoF7ESRKmrZpXFmJqURHDPJwalvhSL8JjsWdgy-59eZfX33xf51ZXMNFIc8xf9nVsLeEbuGh8XTsg9J1v1r0a_AIlay12yPTs5PDzbbTn4Bzc0jEo
linkProvider Springer Nature
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+POH+in+combination+with+STI571+on+the+proliferation+and+apoptosis+of+K562+cells&rft.jtitle=Journal+of+Huazhong+University+of+Science+and+Technology.+Medical+sciences&rft.au=Chen%2C+Yan&rft.au=Hu%2C+Dong&rft.date=2004&rft.issn=1672-0733&rft.volume=24&rft.issue=1&rft.spage=41&rft_id=info:doi/10.1007%2FBF02830702&rft_id=info%3Apmid%2F15165112&rft.externalDocID=15165112
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85740A%2F85740A.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Ftjykdxxb-e%2Ftjykdxxb-e.jpg